A Repeat-Dose, Open-Label, Parallel-Group Study to Assess the Pharmacokinetics of GSK1278863 and Metabolites in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Daprodustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 05 Jun 2017 Planned End Date changed from 1 Jun 2017 to 16 Aug 2017.
- 05 Jun 2017 Planned primary completion date changed from 1 Apr 2017 to 16 Aug 2017.